Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
CorLiCyte® is a live mesenchymal stem cell therapy derived from human umbilical cord lining stem cells, with a proprietary optimised expression of cytokines, growth and cellular factors for the treatment of a number of serious health conditions.
Lead Product(s): Human Umbilical Cord Derived Mesenchymal Stem Cells
Therapeutic Area: Podiatry Product Name: CorLiCyte
Highest Development Status: Phase IProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 16, 2022